Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

trypsin inhibitor BGIT, Momordica charantia

Known as: BGIT trypsin inhibitor, Momordica charantia 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Momordica charantia known as bitter melon is a representative medicinal plant reported to exhibit numerous pharmacological… Expand
Is this relevant?
2014
2014
Diabetes, a common metabolic disorder, is characterized by hyperglycemia. Insulin is the principal mediator of glucose… Expand
Is this relevant?
2013
2013
Momordica charantia (MC) has been used as an alternative therapy for diabetes mellitus. This study analyzed and elucidated… Expand
Is this relevant?
2013
2013
Momordica charantia is commonly known as bitter gourd, balsam pear or karela is a multi-purpose herb. It is cultivated from… Expand
  • table I
  • table II
  • table III
Is this relevant?
2012
2012
Plants are an invaluable source of potential new anti-cancer drugs. Momordica charantia is one of these plants with both edible… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
The present study was undertaken to determine the interaction of rosiglitazone, a PPAR-gamma agonist with methanolic extract of… Expand
  • figure 1
  • figure 5
Is this relevant?
2007
2007
To examine the effects of Momordica charantia on glucose uptake and adiponectin secretion in adipose cells, 3T3-L1 adipocytes… Expand
Is this relevant?
1994
1994
The effect of Momordica charantia on certain key hepatic enzymes was investigated using male Sprague-Dawley rats as the animal… Expand
Is this relevant?
1987
1987
Ginsenosides Rb1, Rb2, Rc and Rg1 inhibited steroidogenesis induced by a maximally active dose of corticotropin in isolated rat… Expand
Is this relevant?
1986
1986
The extra pancreatic effects of the oral hypoglycaemic plant Momordica charantia have been investigated in rats. It was found… Expand
Is this relevant?